Prevalence of Hypertension and Diabetes in Severe COVID-19: A Cross-Sectional Study from Single Center, Kabul
Mohammad Zobair Wardak,Ahmad Farid Daanish,Ershad Ahmad Mushkani,Mohammad Asif Atiq
DOI: https://doi.org/10.2147/idr.s451114
2024-05-01
Infection and Drug Resistance
Abstract:Mohammad Zobair Wardak, 1 Ahmad Farid Daanish, 2 Ershad Ahmad Mushkani, 2 Mohammad Asif Atiq 2 1 Internal Medicine Specialist, Darussalam Hospital, Kabul, Afghanistan; 2 Department of Pharmacology, Kabul University of Medical Sciences, Kabul, Afghanistan Correspondence: Mohammad Asif Atiq, Department of Pharmacology, Kabul University of Medical Sciences, Kabul, Afghanistan, Tel +93777378141, Email Introduction: Previous studies have reported an association between certain medical conditions, such as hypertension and diabetes, and severe COVID-19. Objective: To determine the prevalence of hypertension and diabetes among severe COVID-19 patients who were admitted to the only specialized center for COVID-19 in Kabul, Afghan-Japan Hospital Kabul, Afghanistan. Methods: A cross-sectional design was utilized, including 202 patients, admitted to Afghan-Japan Hospital during the first six months of 2022. Medical records of patients tested positive for COVID-19 via Polymerase chain reaction (PCR) with oxygen saturation levels below 90% at the time of admission were included in the study. Age, sex, and the presence of hypertension and diabetes were the studied variables. Descriptive statistics were used for analysis. Results: The median age of the patients were 63 (IQR=54.75– 75) years. Males and females each accounting for 50% of the total, and the majority of the patients (50.5%) were in the age group 60– 79. Of 202 patients, 143 (70.8%) had hypertension, 42 (20.8%) had diabetes, 147 patients (72.77%) had at least one of these comorbidities. Fifty-five patients (27.22%) were without diabetes and without hypertension. The prevalence of hypertension and diabetes was higher among female, ie, 57.1% and 54.5% respectively. Patients in the 40– 59 year old group had the highest rate of hypertension (75.6%). The highest prevalence of diabetes was seen in the 60– 79 year old group. Conclusion: The study found a higher prevalence of hypertension in severe COVID-19 cases compared to global reports and the general adult population in Afghanistan. The relationship between hypertension and COVID-19 risk needs further investigation. The prevalence of diabetes was also higher, consistent with findings from other countries. Keywords: severe COVID-19, comorbidity, hypertension, diabetes Coronavirus disease (COVID-19) is an infectious disease that is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The COVID-19 pandemic has emerged as a global health challenge, necessitating urgent attention and response worldwide. Initially, researches primarily focused on the respiratory manifestations of the virus. However, emerging evidence now suggests potential implications for cardiovascular health. Notably, certain medical conditions, such as hypertension and diabetes, have garnered significant attention due to their association with severe COVID-19. Among the critical factors under investigation are the association of specific comorbidities with covid-19. It has been reported that the proportion of patients with comorbidities was higher among those admitted to the intensive care unit (ICU) (72.2%) compared to those who were not admitted to the ICU (37.3%). 1 Hypertension and diabetes, given their high disease burdens worldwide and potential impact on COVID-19 severity, stand out as key areas of focus. 1,2 The prevalence of comorbidities like hypertension and diabetes has been consistently linked to severe COVID-19 across different geographical locations. However, it is important to note that the prevalence of these comorbidities can vary due to a range of other factors. 1,2 Numerous studies have investigated the prevalence of hypertension and diabetes in COVID-19 patients, but there is a lack of data from Afghanistan. While some studies have addressed other relevant aspects of COVID-19 in Afghanistan, we did not find any published articles on the prevalence of comorbidities in severe COVID-19 cases. Therefore, this study represents the first attempt to examine the prevalence of hypertension and diabetes among severe COVID-19 patients at a tertiary center in Afghanistan. Understanding the prevalence of these comorbidities in Afghanistan is crucial, as regional variations may exist among COVID-19 inpatients. This knowledge is essential for identifying at-risk populations, guiding clinical management, and allocating resources effectively. Incorporating localized data on comorbidity burdens is vital for gaining insights into the specific health challenges faced by the Afghan population and for designing targeted public health responses. While numerous studies have explored this topic in various global locations, including da -Abstract Truncated-
pharmacology & pharmacy,infectious diseases